Task: Answer the multiple choice question.
Question: Which compound exhibits a 17.413% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a CCN(c1ccc(OC)cc1)S(=O)(=O)c1ccc2c(c1)NC(=O)CS2
b CCOc1ccc(CCNC(=O)c2[nH]c(C)c(C(C)=O)c2CC)cc1OCC
c Cc1cccc[n+]1C1C(c2ccc([N+](=O)[O-])cc2)C(C#N)=C(C(=C=[N-])C#N)NC1(O)C1CC1
d C[N+]1(CN2C(=O)C3C4C=CC(C4)C3C2=O)CCCCC1.[I-]
Answer: d. C[N+]1(CN2C(=O)C3C4C=CC(C4)C3C2=O)CCCCC1.[I-]
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C[N+]1(CN2C(=O)C3C4C=CC(C4)C3C2=O)CCCCC1.[I-]
C[N+]1(CN2C(=O)C3C4C=CC(C4)C3C2=O)CCCCC1.[I-]
4-[(1-methylpiperidin-1-ium-1-yl)methyl]-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione;iodide